Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy P Mendenhall

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2026
Ten-year outcomes for image-guided moderately hypofractionated proton therapy for prostate cancerRandal H Henderson, Curtis M Bryant, R Charles Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancerNancy P Mendenhall, Bradford S Hoppe, Romaine C Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2014
Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 studyBradford S Hoppe, Stella Flampouri, Robert Zaiden, et al.
Acta Oncologica (Stockholm, Sweden)|July 4, 2014
Local control in non-metastatic medulloblastomaKaitlin M Christopherson, Julie A Bradley, Ronny L Rotondo, et al.
International Journal of Particle Therapy|February 7, 2022
Insurance Approval for Definitive Proton Therapy for Prostate CancerWilliam M Mendenhall, Eric D Brooks, Stephanie Smith, et al.
Acta Oncologica (Stockholm, Sweden)|September 18, 2014
A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancerThomas P Kole, R Charles Nichols, Song Lei, et al.
Cancer|January 19, 2012
Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and youngerBradford S Hoppe, Romaine C Nichols, Randal H Henderson, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancerLisa McGee, Nancy P Mendenhall, Randal H Henderson, et al.
Cancer Investigation|March 7, 2019
Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate CancerR Charles Nichols, Christopher G Morris, Curtis Bryant, et al.
Clinical Lung Cancer|July 6, 2011
Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric studyR Charles Nichols, Soon N Huh, Randal H Henderson, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2026
Ten-year outcomes for image-guided moderately hypofractionated proton therapy for prostate cancerRandal H Henderson, Curtis M Bryant, R Charles Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancerNancy P Mendenhall, Bradford S Hoppe, Romaine C Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2014
Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 studyBradford S Hoppe, Stella Flampouri, Robert Zaiden, et al.
Acta Oncologica (Stockholm, Sweden)|July 4, 2014
Local control in non-metastatic medulloblastomaKaitlin M Christopherson, Julie A Bradley, Ronny L Rotondo, et al.
International Journal of Particle Therapy|February 7, 2022
Insurance Approval for Definitive Proton Therapy for Prostate CancerWilliam M Mendenhall, Eric D Brooks, Stephanie Smith, et al.
Acta Oncologica (Stockholm, Sweden)|September 18, 2014
A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancerThomas P Kole, R Charles Nichols, Song Lei, et al.
Cancer|January 19, 2012
Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and youngerBradford S Hoppe, Romaine C Nichols, Randal H Henderson, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancerLisa McGee, Nancy P Mendenhall, Randal H Henderson, et al.
Cancer Investigation|March 7, 2019
Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate CancerR Charles Nichols, Christopher G Morris, Curtis Bryant, et al.
Clinical Lung Cancer|July 6, 2011
Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric studyR Charles Nichols, Soon N Huh, Randal H Henderson, et al.
Pageof 17